MedPath

ThoHSpEkt Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With Free-hand SPECT

Phase 2
Terminated
Conditions
Solitary Pulmonary Nodule
Bronchial Neoplasms
Interventions
Drug: Radioactive labelling of pulmonary nodules
Device: CT guided radioactive labelling
Device: Electromagnetic guided bronchoscopic radioactive labelling
Registration Number
NCT02050724
Lead Sponsor
Cantonal Hospital of St. Gallen
Brief Summary

Title ThoHSpEkt

Study Design Pilot Study concerning the technical operative methods and a phase II study concerning the radiopharmaceutical (therapeutic-explorative study with an approved drug in a new indication)

Location Kantonsspital St.Gallen

Aim Proof of feasibility of thoracoscopic ectomy of radioactively marked pulmonary nodules with the help of free-hand SPECT.

Background In the Cantonal Hospital of St.Gallen an average of 30 - 40 patients will be operated with thoracoscopic ectomy for a pulmonary nodule. When localisation of the nodule is not possible a switch to minithoracotomy is performed.

Study intervention Marking of pulmonary nodules with radioactivity. Free-hand SPECT guided surgery

Risks Risks of bronchoscopic or CT-intervention Radiation risk (minimal)

Rational for patient number 10 patients for each group are enough to prove the feasibility, to manage difficulties and to record complications

Duration approximately 24 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
11
Inclusion Criteria
  • age over 18 years
  • Planed thoracoscopic surgery of a pulmonary nodule
  • Informed consent
Exclusion Criteria
  • mental incapacity
  • contraindications for this treatment
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
CT guided labellingCT guided radioactive labellingCT guided radioactive labelling of pulmonary nodules followed by handheld-SPECT guided thoracoscopic surgery.
Electromagnetic bronchoscopic labellingRadioactive labelling of pulmonary nodulesElectromagnetic guided bronchoscopic labeling of pulmonary nodules followed by handheld-SPECT guided thoracoscopic surgery.
CT guided labellingRadioactive labelling of pulmonary nodulesCT guided radioactive labelling of pulmonary nodules followed by handheld-SPECT guided thoracoscopic surgery.
Electromagnetic bronchoscopic labellingElectromagnetic guided bronchoscopic radioactive labellingElectromagnetic guided bronchoscopic labeling of pulmonary nodules followed by handheld-SPECT guided thoracoscopic surgery.
Primary Outcome Measures
NameTimeMethod
Successful thoracoscopic ectomies1 week

Rate of successful thoracoscopic ectomies (i.e. without reversion to (mini-)thoracotomy and without any complications)

Secondary Outcome Measures
NameTimeMethod
CT labelling1 day

Success rate of CT labelling

CT Labelling complications1 day

complication rate attributable to CT labelling

Successful labeling using electro-magnetically navigated bronchoscopy1 day

Rate of successful labeling using electro-magnetically navigated bronchoscopy

Complications after labeling using electro-magnetically navigated bronchoscopy1 day

Complication rate after labeling using electro-magnetically navigated bronchoscopy

Trial Locations

Locations (1)

Cantonal Hospital St.Gallen

🇨🇭

St. Gallen, Switzerland

© Copyright 2025. All Rights Reserved by MedPath